A detailed history of Drive Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Drive Wealth Management, LLC holds 9,344 shares of NVO stock, worth $1.01 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
9,344
Previous 9,344 -0.0%
Holding current value
$1.01 Million
Previous $1.11 Million -0.0%
% of portfolio
0.29%
Previous 0.29%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.07 - $145.42 $11,192 - $13,669
-94 Reduced 1.0%
9,344 $1.11 Million
Q2 2024

Jul 31, 2024

SELL
$122.71 - $146.91 $6,380 - $7,639
-52 Reduced 0.55%
9,438 $1.35 Million
Q1 2024

Apr 22, 2024

SELL
$102.11 - $135.92 $33,083 - $44,038
-324 Reduced 3.3%
9,490 $1.22 Million
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $6,232 - $7,486
71 Added 0.73%
9,814 $1.02 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $465,339 - $1.02 Million
5,117 Added 110.61%
9,743 $886,000
Q2 2023

Jul 14, 2023

BUY
$155.98 - $172.65 $4,055 - $4,488
26 Added 0.57%
4,626 $748,000
Q1 2023

Apr 13, 2023

SELL
$132.34 - $159.14 $111,033 - $133,518
-839 Reduced 15.43%
4,600 $732,000
Q4 2022

Jan 27, 2023

BUY
$102.55 - $135.33 $90,654 - $119,631
884 Added 19.41%
5,439 $0
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $38,016 - $46,655
399 Added 9.6%
4,555 $454,000
Q2 2022

Nov 14, 2022

BUY
$103.24 - $121.81 $10,633 - $12,546
103 Added 2.54%
4,156 $463,000
Q1 2022

Nov 14, 2022

BUY
$93.1 - $112.54 $37,612 - $45,466
404 Added 11.07%
4,053 $454,000
Q4 2021

Nov 14, 2022

BUY
$95.88 - $117.08 $349,866 - $427,224
3,649 New
3,649 $409,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Drive Wealth Management, LLC Portfolio

Follow Drive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drive Wealth Management, LLC with notifications on news.